Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Larson

Showing results (91-100 of 208) with videos related to

Pageof 21
Sort By:
Blood|October 9, 1998
CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapyD Roulston, R Espinosa, G Nucifora, et al.
Blood|October 1, 1996
Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion intervalS K Horrigan, C A Westbrook, A H Kim, et al.
Leukemia|December 1, 1990
Complex rearrangement of the T cell receptor in large granular lymphocytosis associated with myeloid suppressionL C Platanias, R A Larson, J W Vardiman, et al.
The American Journal of Medicine|May 1, 1984
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemiaR A Larson, K Kondo, J W Vardiman, et al.
Blood|March 15, 1993
Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansionJ Anastasi, J Feng, M M Le Beau, et al.
Leukemia|February 20, 2003
A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211J C Byrd, B Peterson, L Piro, et al.
Leukemia|April 1, 1995
The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemiaJ Anastasi, J Feng, M M Le Beau, et al.
Leukemia|February 1, 1991
Circulating immune complexes correlate with remission duration in acute myeloid leukemiaR A Larson, C L Lukin, K M Daly, et al.
Blood|February 15, 1989
Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q)M M Le Beau, R S Lemons, R Espinosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013M L Hensley, B Peterson, R T Silver, et al.
Pageof 21

Showing results (91-100 of 208) with videos related to

Sort By:
Pageof 21
Blood|October 9, 1998
CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapyD Roulston, R Espinosa, G Nucifora, et al.
Blood|October 1, 1996
Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion intervalS K Horrigan, C A Westbrook, A H Kim, et al.
Leukemia|December 1, 1990
Complex rearrangement of the T cell receptor in large granular lymphocytosis associated with myeloid suppressionL C Platanias, R A Larson, J W Vardiman, et al.
The American Journal of Medicine|May 1, 1984
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemiaR A Larson, K Kondo, J W Vardiman, et al.
Blood|March 15, 1993
Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansionJ Anastasi, J Feng, M M Le Beau, et al.
Leukemia|February 20, 2003
A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211J C Byrd, B Peterson, L Piro, et al.
Leukemia|April 1, 1995
The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemiaJ Anastasi, J Feng, M M Le Beau, et al.
Leukemia|February 1, 1991
Circulating immune complexes correlate with remission duration in acute myeloid leukemiaR A Larson, C L Lukin, K M Daly, et al.
Blood|February 15, 1989
Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q)M M Le Beau, R S Lemons, R Espinosa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013M L Hensley, B Peterson, R T Silver, et al.
Pageof 21